Trademark applications and grants for Human Genome Sciences Inc. Human Genome Sciences Inc has 84 trademark applications. The latest application filed is for "ABTHRAX"
Patent Application | Date |
---|---|
ALBUMIN FUSION PROTEINS 20170096472 - 15/381347 Rosen; Craig A. ;   et al. | 2017-04-06 |
USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE 20160311914 - 15/156437 MIGONE; Thi-Sau ;   et al. | 2016-10-27 |
ALBUMIN FUSION PROTEINS 20160152687 - 15/041517 Rosen; Craig A. ;   et al. | 2016-06-02 |
ALBUMIN FUSION PROTEINS 20150329619 - 14/818972 Rosen; Craig A. ;   et al. | 2015-11-19 |
USE OF B LYMPHOCYTE STIMULATOR PROTEIN ANTAGONISTS TO PROMOTE TRANSPLANTATION TOLERANCE 20150322158 - 14/703966 MIGONE; Thi-Sau ;   et al. | 2015-11-12 |
NCAGE Code | 31SH4 | HUMAN GENOME SCIENCES, INC. |
CAGE Code | 31SH4 | HUMAN GENOME SCIENCES, INC. |
SEC | 0000901219 | HUMAN GENOME SCIENCES INC of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.